| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Contineum Therapeutics, Inc. (CTNM) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. CTNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 249.2K | $3.82M | - | |
| Other | 206.4K | $3.17M | - | |
| CFO | 192.0K | $2.95M | - | |
| Other | 135.2K | $2.08M | -25 | |
| CEO | 19.7K | $302.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Lorrain Daniel S.68 | Chief Scientific Officer | Sale+OE | 1,040 | $16.00 | $16,640.00 | -0.4% | - | - | |
| Jul 8, 2026 | Stengone Carmine N. | CEO And President | Sale+OE | 2,500 | $16.00 | $40,000.00 | -12.7% | - | - | |
| Jun 1, 2026 | Lorrain Daniel S.68 | Chief Scientific Officer | Sell | 4,170 | $13.16 | $54,862.19 | -2.9% | - | - | |
| May 1, 2026 | Lorrain Daniel S.68 | Chief Scientific Officer | Sell | 4,170 | $13.12 | $54,694.20 | -1.4% | +19.3% | - | |
| Mar 2, 2026 | Watkins Tim48 | CMO &Head Of Development | Sale+OE | 3,611 | $15.02 | $54,220.25 | -100% | -11.9% | - | |
| Feb 3, 2026 | Lorrain Daniel S.68 | Chief Scientific Officer | Sell | 4,170 | $14.94 | $62,305.47 | -1.3% | -13.2% | - | |
| Jan 28, 2026 | Watkins Tim48 | CMO &Head Of Development | Sale+OE | 3,611 | $14.18 | $51,188.25 | -81.7% | -13.1% | - | |
| Jan 5, 2026 | Lorrain Daniel S.68 | Chief Scientific Officer | Sell | 4,170 | $10.44 | $43,543.16 | -1.3% | +34.4% | - | |
| Dec 29, 2025 | Watkins Tim48 | CMO &Head Of Development | Sale+OE | 3,611 | $12.06 | $43,558.41 | -100% | +3.2% | - | |
| Dec 23, 2025 | Lorrain Daniel S.68 | Chief Scientific Officer | Sell | 4,170 | $12.23 | $51,009.11 | -2.5% | +0.9% | - |